Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways

Clinical Immunology

Volumn 160, Issue 2, 2015, Pages 180-187

  Thanei, Sophia ^a   Vanhecke, Dominique ^a,b   Trendelenburg, Marten ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Anti C1q; Classical pathway; Complement; Lectin pathway; Lupus nephritis; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4B; IMMUNOGLOBULIN G; AUTOANTIBODY; COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN A;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; MIDDLE AGED;

ADULT; AGED; AUTOANTIBODIES; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED;

EID: 84938076153     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.06.014     Document Type: Article

References (52)

1. Mok C.C., Lau C.S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 2003, 56:481-490.
2. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2001, 2:764-766.
3. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
4. Sjöberg A.P., Trouw L.A., Blom A.M. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009, 30:83-90.
5. Tegla C.A., Cudrici C., Patel S., Trippe R., Rus V., Niculescu F., Rus H. Membrane attack by complement: the assembly and biology of terminal complement complexes. Immunol. Res. 2011, 51:45-60.
6. Pickering M.C., Walport M.J. Links between complement abnormalities and systemic lupus erythematosus. Rheumatology (Oxford) 2000, 39:133-141.
7. Aringer M., Günther C., Lee-Kirsch M.A. Innate immune processes in lupus erythematosus. Clin. Immunol. 2013, 147:216-222.
8. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998, 19:56-59.
9. Bigler C., Hopfer H., Danner D., Schaller M., Mihatsch M.J., Trendelenburg M. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Nephrol. Dial. Transplant. 2011, 26:1220-1228.
10. Marto N., Bertolaccini M.L., Calabuig E., Hughes G.R., Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann. Rheum. Dis. 2005, 64:444-448.
11. Coremans I.E., Spronk P.E., Bootsma H., Daha M.R., van der Voort E.A., Kater L., Breedveld F.C., Kallenberg C.G. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am. J. Kidney Dis. 1995, 26:595-601.
12. Trouw L.A., Groeneveld T.W., Seelen M.A., Duijs J.M., Bajema I.M., Prins F.A., Kishore U., Salant D.J., Verbeek J.S., van Kooten C., Daha M.R. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J. Clin. Invest. 2004, 114:679-688.
13. Antes U., Heinz H.P., Loos M. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum. 1988, 31:457-464.
14. Bigler C., Schaller M., Perahud I., Osthoff M., Trendelenburg M. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J. Immunol. 2009, 183:3512-3521.
15. Pang Y., Yang X.W., Song Y., Yu F., Zhao M.H. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro. Immunobiology 2014, 219:980-989.
16. Daha N.A., Banda N.K., Roos A., Beurskens F.J., Bakker J.M., Daha M.R., Trouw L.A. Complement activation by (auto-) antibodies. Mol. Immunol. 2011, 48:1656-1665.
17. Trouw L.A., Haisma E.M., Levarht E.W., van der Woude D., Ioan-Facsinay A., Daha M.R., Huizinga T.W., Toes R.E. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 2009, 60:1923-1931.
18. Xiao H., Schreiber A., Heeringa P., Falk R.J., Jennette J.C. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am. J. Pathol. 2007, 170:52-64.
19. Banda N.K., Wood A.K., Takahashi K., Levitt B., Rudd P.M., Royle L., Abrahams J.L., Stahl G.L., Holers V.M., Arend W.P. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum. 2008, 58:3081-3089.
20. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., Hollmann T.J., Casali P., Caroll M.C., Wetsel R.A., Lambris J.D., Holers V.M., Salmon J.E. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 2003, 112:1644-1654.
21. Trendelenburg M. The complement system in cryoglobulinemia. HCV Infection and Cryoglobulinemia 2012, 85-89. Springer Verlag. F. Dammacco (Ed.).
22. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
23. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
24. Uwatoko S., Aotsuka S., Okawa M., Egusa Y., Yokohari R., Aizawa C., Suzuki K. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1987, 69:98-106.
25. Siegert C.E., Daha M.R., Halma C., van der Voort E.A., Breedveld F.C. IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin. Exp. Rheumatol. 1992, 10:19-23.
26. Trendelenburg M., Lopez-Trascasa M., Potlukova E., Moll S., Regenass S., Frémeaux-Bacchi V., Martinez-Ara J., Jancova E., Picazo M.L., Honsova E., Tesar V., Sadallah S., Schifferli J. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol. Dial. Transplant. 2006, 21:3115-3121.
27. Coremans I.E., Daha M.R., van der Voort E.A., Siegert C.E., Breedveld F.C. Subclass distribution of IgA and IgG antibodies against Clq in patients with rheumatic diseases. Scand. J. Immunol. 1995, 41:391-397.
28. Pfueller B., Wolbart K., Bruns A., Burmester G.R., Hiepe F. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum. 2001, 44:1962-1963.
29. Roos A., Bouwman L.H., van Gijlswijk-Janssen D.J., Faber-Krol M.C., Stahl G.L., Daha M.R. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 2001, 167:2861-2868.
30. McMullen M.E., Hart M.L., Walsh M.C., Buras J., Takahashi K., Stahl G.L. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology 2006, 211:759-766.
31. Siegert C.E., Daha M.R., Lobatto S., van der Voort E.A., Breedveld F.C. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus. Immunol. Res. 1992, 11:91-97.
32. Harboe M., Mollnes T.E. The alternative complement pathway revisited. J. Cell. Mol. Med. 2008, 12:1074-1084.
33. Trouw L.A., Blom A.M., Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol. Immunol. 2008, 45:1199-1207.
34. Moura C.G., Lima I., Barbosa L., Athanazio D., Reis E., Reis M., Burlingame R.W., Santiago M.B. Anti-C1q antibodies: association with nephritis and disease activity in systemic lupus erythematosus. J. Clin. Lab. Anal. 2009, 23:19-23.
35. Oelzner P., Deliyska B., Fünfstück R., Hein G., Herrmann D., Stein G. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Clin. Rheumatol. 2003, 22:271-278.
36. Vanhecke D., Roumenina L.T., Wan H., Osthoff M., Schaller M., Trendelenburg M. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay. Arthritis Rheum. 2012, 64:3706-3714.
37. Cook H.T., Botto M. Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2006, 2:330-337.
38. Sato N., Ohsawa I., Nagamachi S., Ishii M., Kusaba G., Inoshita H., Toki A., Horikoshi S., Ohi H., Matsushita M., Tomino Y. Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis. Lupus 2011, 20:1378-1386.
39. Trouw L.A., Seelen M.A., Duijs J.M., Wagner S., Loos M., Bajema I.M., van Kooten C., Roos A., Daha M.R. Activation of the lectin pathway in murine lupus nephritis. Mol. Immunol. 2005, 42:731-740.
40. Nisihara R.M., Magrini F., Mocelin V., Messias-Reason I.J. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients. Hum. Immunol. 2013, 74:907-910.
41. Kim M.K., Maeng Y.I., Lee S.J., Lee I.H., Bae J., Kang Y.N., Park B.T., Park K.K. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. Int. J. Clin. Exp. Pathol. 2013, 6:2157-2167.
42. Mannik M., Wener M.H. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997, 40:1504-1511.
43. O'Flynn J., Flierman R., van der Pol P., Rops A., Satchell S.C., Mathieson P.W., van Kooten C., van der Vlag J., Berden J.H., Daha M.R. Nucleosomes and C1q bound to glomerular endothelial cells serve as targets for autoantibodies and determine complement activation. Mol. Immunol. 2011, 49:75-83.
44. Uwatoko S., Gauthier V.J., Mannik M. Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin. Immunol. Immunopathol. 1991, 61:268-273.
45. Taylor P.R., Carugati A., Fadok V.A., Cook H.T., Andrews M., Carroll M.C., Savill J.S., Henson P.M., Botto M., Walport M.J. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 2000, 192:359-366.
46. Fraser D.A., Laust A.K., Nelson E.L., Tenner A.J. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J. Immunol. 2009, 183:6175-6185.
47. Nauta A.J., Castellano G., Xu W., Woltman A.M., Borrias M.C., Daha M.R., van Kooten C., Roos A. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J. Immunol. 2004, 173:3044-3050.
48. Mevorach D., Mascarenhas J.O., Gershov D., Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 1998, 188:2313-2320.
49. Ogden C.A., deCathelineau A., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.A., Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001, 194:781-795.
50. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., Roos A. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 2002, 32:1726-1736.
51. Kozyro I., Korosteleva L., Chernoshej D., Danner D., Sukalo A., Trendelenburg M. Autoantibodies against complement C1q in acute post-streptococcal glomerulonephritis. Clin. Immunol. 2008, 128:409-414.
52. Barilla-Labarca M.L., Toder K., Furie R. Targeting the complement system in systemic lupus erythematosus and other diseases. Clin. Immunol. 2013, 148:313-321.